Stock SRDX SURMODICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Surmodics, Inc.

Equities

SRDX

US8688731004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
41.95 USD -0.12% Intraday chart for Surmodics, Inc. 0.00% +15.41%
Jun. 10 Surmodics Signs Group Purchasing Deal With Premier MT
May. 30 Barrington Research Downgrades SurModics to Market Perform From Outperform MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Surmodics Signs Group Purchasing Deal With Premier
MT
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
BU
Barrington Research Downgrades SurModics to Market Perform From Outperform
MT
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.
PR
Needham Downgrades SurModics to Hold From Buy
MT
Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders
PR
SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Surmodics to GTCR
AQ
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday
MT
Rising Bond Yields Fueling Losses for US Equity Futures Pre-Bell
MT
Sector Update: Health Care
MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday After Fed Speaker's Hawkish Comments
MT
SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders
BU
Top Premarket Gainers
MT
SurModics Agrees to be Acquired by Private Equity Firm GTCR for $627 Million; Shares Rise Pre-Bell
MT
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million
BU
GTCR LLC entered into a definitive agreement to acquire Surmodics, Inc. for approximately $620 million.
CI
Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating
MT
Top Midday Gainers
MT
Transcript : Surmodics, Inc., Q2 2024 Earnings Call, May 01, 2024
SurModics: Fiscal Q2 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SRDX Stock
  4. News Surmodics, Inc.